Location History:
- Eltham, AU (2006)
- Carlton, AU (2012 - 2013)
Company Filing History:
2 out of 4 
2 out of 13 
1 out of 1 Years Active: 2006-2013
Title: **Exploring the Innovations of Frederick A O Mendelsohn**
Introduction
Frederick A O Mendelsohn, based in Carlton, Australia, is a notable inventor recognized for his contributions to medical research and innovation. With a total of three patents to his name, his work primarily focuses on the development of therapeutic applications that have the potential to enhance memory and learning functions.
Latest Patents
Mendelsohn’s latest patents include the groundbreaking invention related to Insulin-regulated aminopeptidase (IRAP) inhibitors. This invention pertains to inhibitors of insulin-regulated aminopeptidase (IRAP) and the methods for inhibiting the same, alongside compositions that comprise these inhibitors. These innovations are particularly useful in therapeutic applications aimed at improving cognitive functions such as memory and learning.
Career Highlights
Throughout his career, Mendelsohn has made significant strides in the field of medical research. He has held positions at prestigious institutes including the Howard Florey Institute and St. Vincent's Institute of Medical Research, where he has been pivotal in advancing research strategies and developing novel therapeutic approaches.
Collaborations
Mendelsohn has collaborated with esteemed colleagues, including Siew Yeen Chai and Michael William Parker. Their combined efforts have contributed to the advancement of medical research and innovations, particularly in the field of neurobiology.
Conclusion
Frederick A O Mendelsohn is an influential figure in the realm of medical innovation, particularly with regard to the development of IRAP inhibitors. His patents stand as a testament to his commitment to enhancing cognitive functions and improving therapeutic methods. As his career progresses, his contributions continue to shape the landscape of medical research and patent development.